Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from DRI Healthcare ( ($TSE:DHT.UN) ).
DRI Healthcare Trust has announced it will host a conference call on November 6, 2025, to discuss its third quarter financial results, which will be released the day before. This event provides an opportunity for stakeholders to engage with the company’s management and gain insights into its financial performance and strategic direction.
The most recent analyst rating on ($TSE:DHT.UN) stock is a Hold with a C$15.50 price target. To see the full list of analyst forecasts on DRI Healthcare stock, see the TSE:DHT.UN Stock Forecast page.
Spark’s Take on TSE:DHT.UN Stock
According to Spark, TipRanks’ AI Analyst, TSE:DHT.UN is a Neutral.
The overall stock score is primarily influenced by strong financial stability and positive technical indicators. However, the high P/E ratio raises valuation concerns, which significantly impacts the score. The absence of earnings call data and corporate events limits additional insights.
To see Spark’s full report on TSE:DHT.UN stock, click here.
More about DRI Healthcare
DRI Healthcare is a leader in the global pharmaceutical royalty monetization industry, having invested over $3 billion since 1989 in acquiring royalties on more than 45 drugs. The company is listed on the Toronto Stock Exchange and focuses on financing innovations in the life sciences sector.
Average Trading Volume: 38,138
Technical Sentiment Signal: Buy
Current Market Cap: C$798.1M
See more insights into DHT.UN stock on TipRanks’ Stock Analysis page.